首頁 > 市場調查報告書 > 製藥

癌症

市場調查報告書

商品編碼

1672688

全球獸醫腫瘤市場：按動物類型、按治療類型、按劑型、按應用、按分銷管道、按地區

Veterinary Oncology Market, By Animal Type, By Therapy Type, By Mode of Administration, By Application, By Distribution Channel, By Geography

出版日期: 2025年02月17日 | 出版商:

Coherent Market Insights | 英文 225 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球獸醫腫瘤市場規模估計為 8.105 億美元，預計到 2032 年將達到 17.706 億美元，2025 年至 2032 年的複合年成長率為 11.8%。

報告範圍		報告詳細資訊
基準年	2024	2025 年市場規模	8.105億美元
效能資料	2020-2024	預測期	2025-2032
預測期：2025-2032年複合年成長率：	11.80％	2032 年價值預測	17.706 億美元

數字。 2025 年獸醫腫瘤學市場佔有率（按地區分類）

由於動物保健支出的增加和寵物擁有量的增加，獸醫腫瘤市場正在經歷顯著的成長。人類與動物之間關係的加深以及對寵物癌症認知的不斷提高，推動了對獸醫腫瘤學先進診斷方法和治療程序的需求。此外，狗和貓中淋巴瘤、乳腺腫瘤、口腔黑色素瘤和肥大細胞瘤等癌症的發生率不斷增加，也增加了對有效治療方案和早期檢測的需求。獸醫腫瘤學家和腫瘤學專家的數量不斷增加，以及開發創新配方的持續研究，進一步推動了全球市場的擴張。然而，癌症治療和診斷程序的高昂費用仍然是一個巨大的挑戰。

市場動態：

全球獸醫腫瘤市場的成長受到寵物癌症發生率上升、寵物保險採用率增加、獸醫保健支出增加和技術進步的推動。統計數據顯示，10歲以上的狗中超過50%會罹患癌症，其中淋巴瘤是狗中最常見的血癌。快速的都市化、核心家庭和日益增強的孤獨感正在推高全球的寵物擁有率。這使得寵物飼主更加關注寵物的健康，並在優質治療上花費更多。各種組織都在資金支持與獸醫腫瘤學相關的臨床試驗和研究活動，這對市場成長起著至關重要的作用。然而，預測期內腫瘤藥物、診斷測試和手術的高成本以及新興經濟體缺乏認知預計將阻礙市場擴張。透過社群媒體宣傳活動和會議持續傳播有關寵物癌症的認知，預計將為市場的主要企業提供大量有利可圖的機會。

本研究的主要特點

本報告對全球獸醫腫瘤市場進行了詳細分析，並以 2024 年為基準年，展示了預測期（2025-2032 年）的市場規模和複合年成長率。
它還強調了各個領域的潛在收益成長機會，並說明了該市場的引人注目的投資提案矩陣。
它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，概述了全球獸醫腫瘤學市場的主要企業。
主要公司包括 Zoetis Inc.、Elanco、AB Science、Boehringer Ingelheim International GmbH、Zenoaq、VetDC、Morphogenesis, Inc.、Karyopharm Therapeutics, Inc.、Regeneus Ltd.、AdvaVet, Inc.、Rhizen Pharmaceutical SA.、PetCure Oncology Ltd
本報告的見解可以幫助負責人和企業經營團隊就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球獸醫腫瘤學市場迎合了該行業的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過用於分析全球獸醫腫瘤學市場的各種策略矩陣更輕鬆地做出決策。

公司簡介
- Zoetis Inc.
- Elanco
- AB Science
- Boehringer Ingelheim International GmbH
- Zenoaq
- VetDC
- Morphogenesis, Inc.
- Karyopharm Therapeutics, Inc.
- Regeneus Ltd.
- AdvaVet, Inc.
- Rhizen Pharmaceutical SA.
- PetCure Oncology
- Varian Medical Systems
- Accuray Incorporated
- One Health
- Regeneus Ltd.

第 12 章分析師建議

命運之輪
分析師觀點
Coherent Opportunity Map（COM）

第13章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI2995

Global Veterinary Oncology Market is estimated to be valued at USD 810.5 Mn in 2025 and is expected to reach USD 1,770.6 Mn by 2032, growing at a compound annual growth rate (CAGR) of 11.8% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 810.5 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	11.80%	2032 Value Projection:	USD 1,770.6 Mn

Figure. Veterinary Oncology Market Share (%), By Region 2025

The veterinary oncology market is experiencing significant growth due to rising animal healthcare expenditure and increasing pet ownership. Growing human-animal bonds and rising awareness about cancer in companion animals are propelling demand for advanced diagnostic methods and therapeutic procedures for veterinary oncology. Moreover, increasing incidence of cancers such as lymphoma, mammary tumor, oral melanoma, and mast cell tumors in dogs and cats is driving the need for effective treatment options and early detection. Growing number of veterinary oncologists and oncology specialists along with ongoing research for developing innovative drug formulations are further supporting market expansion on a global level. However, high costs associated with cancer therapies and diagnostic procedures remain a major challenge.

Market Dynamics:

The global veterinary oncology market growth is driven by rising incidence of cancer in companion animals, increase in pet insurance purchases, growing animal health expenditure, and technological advancements. According to statistics, over 50% of dogs over the age of 10 will develop cancer and lymphoma is the most common blood cancer in dogs. Rapid urbanization accompanied with rising nuclear families and increasing loneliness levels have boosted pet adoption rates globally. This has led to pet owners becoming more aware regarding the health of their pets and willing to spend more on premium treatments. Various organizations are financially supporting clinical trials and research activities related to veterinary oncology which is playing a significant role in market growth. However, high costs associated with oncology medications, diagnostic tests, surgeries, and lack of awareness in developing nations are anticipated to hamper the market expansion during the forecast period. Ongoing initiatives to spread awareness regarding cancer in pets through social media campaigns and conferences are expected to bring numerous lucrative opportunities for key players in the market.

Key Features of the Study:

This report provides an in-depth analysis of the global veterinary oncology market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global veterinary oncology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this includes Zoetis Inc., Elanco, AB Science, Boehringer Ingelheim International GmbH, Zenoaq, VetDC, Morphogenesis, Inc., Karyopharm Therapeutics, Inc., Regeneus Ltd., AdvaVet, Inc., Rhizen Pharmaceutical SA., PetCure Oncology, Varian Medical Systems, Accuray Incorporated, One Health, and Regeneus Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global veterinary oncology market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary oncology market

Detailed Segmentation-

By Animal Type:
- Companion Animal
- Equine
- Canine
- Feline
- Livestock Animal
By Therapy Type:
- Chemotherapy
- Combination Therapy
- Immunotherapy
- Targeted Therapy
By Mode of Administration:
- Oral
- Intravenous
By Application:
- Canine Lymphoma
- Osteosarcoma (OSA)
- Mast Cell Cancer
- Melanoma
- Others
By Distribution Channel:
- Hospital Pharmacies
- Government Agencies
- Retail Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Zoetis Inc.
- Elanco
- AB Science
- Boehringer Ingelheim International GmbH
- Zenoaq
- VetDC
- Morphogenesis, Inc.
- Karyopharm Therapeutics, Inc.
- Regeneus Ltd.
- AdvaVet, Inc.
- Rhizen Pharmaceutical SA.
- PetCure Oncology
- Varian Medical Systems
- Accuray Incorporated
- One Health
- Regeneus Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Animal Type
- Market Snapshot, By Therapy Type
- Market Snapshot, By Mode of Administration
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Epidemiology
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Veterinary Oncology Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Veterinary Oncology Market, By Animal Type, 2020 - 2032, (USD Mn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Companion Animal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Equine
Canine
Feline
Livestock Animal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Veterinary Oncology Market, By Therapy Type, 2020 - 2032, (USD Mn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Chemotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Combination Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Immunotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Targeted Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Veterinary Oncology Market, By Mode of Administration, 2020 - 2032, (USD Mn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Intravenous
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Veterinary Oncology Market, By Application, 2020 - 2032, (USD Mn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Canine Lymphoma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Osteosarcoma (OSA)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Mast Cell Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Melanoma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Veterinary Oncology Market, By Distribution Channel, 2020 - 2032, (USD Mn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Government Agencies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

10. Global Veterinary Oncology Market, By Region, 2020 - 2032, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa

11. Competitive Landscape

Company Profiles
- Zoetis Inc.*
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Elanco
- AB Science
- Boehringer Ingelheim International GmbH
- Zenoaq
- VetDC
- Morphogenesis, Inc.
- Karyopharm Therapeutics, Inc.
- Regeneus Ltd.
- AdvaVet, Inc.
- Rhizen Pharmaceutical SA.
- PetCure Oncology
- Varian Medical Systems
- Accuray Incorporated
- One Health
- Regeneus Ltd.